Akso Health Group current report, Q2 FY2018

Business Context and Reporting Period

This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of June 2018. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on June 4, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.

Key Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.

Material Changes

The filing text does not provide information regarding material changes versus the prior comparable period.

Guidance, Outlook, and Risks

The filing text does not include management commentary, guidance, outlook, risks, contingencies, or details on unusual items. The content is limited to the cover page, signature block, and exhibit index.

Investor Verification Checklist

  • Verify the content of the attached Press Release (Exhibit 99.1) for specific financial results or operational updates.
  • Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed in the filing.
  • Review the full text of the press release to obtain any missing financial metrics or material event details.